First Analysis acted as the exclusive financial advisor to Mednet in its sale to CRScube

CHICAGO – Dec. 4, 2025 – First Analysis acted as the exclusive financial advisor to Mednet, a leading provider of eClinical data management software, in its sale to CRScube. The transaction brings together two established eClinical technology providers whose complementary capabilities support the growing demand for flexible, integrated clinical research solutions across North America and Asia.

Together, the organizations offer a comprehensive suite of eClinical technologies spanning electronic data capture (EDC), randomization and trial supply management (RTSM), electronic patient-reported outcomes (ePRO), clinical trial management systems (CTMS), and electronic trial master file (eTMF). This combined portfolio strengthens the companies’ shared objective to improve trial design, data management and operational efficiency for pharmaceutical, biotechnology and medical device sponsors, as well as contract research organizations (CROs).

“The opportunity to join CRScube marks an important new chapter for Mednet. For over two decades, we have worked side by side with sponsors and CROs, not only to support their studies but to truly understand the pressures, objective and patient impact behind every trial. Joining CRScube allows us to build on that foundation and scale our impact even further,” said Rob Robertson, CEO of Mednet. “We are grateful to First Analysis for their deep understanding of our business and mission, and for guiding us through a process that aligned strategic value with long-term purpose.”

“In a rapidly evolving eClinical ecosystem, scale, geographic reach, functionality and integration are becoming more critical to how technology providers support clinical research,” said Joe Munda, Managing Director at First Analysis. “Mednet has long focused on practical innovation grounded in strong client relationships. We viewed CRScube as uniquely positioned to build on that foundation. Our work centered on crystallizing Mednet’s value proposition and identifying a partner who could amplify its strengths. CRScube shares that vision, resulting in a fully integrated global end-to-end eClinical platform.”

First Analysis focuses its advisory services on highly specialized, industry specific B2B software companies like Mednet. Drawing on its extensive pharma IT research and experience, First Analysis was actively engaged with the company throughout the transaction process, including preparation, positioning, investor coordination and contact, due diligence and negotiation.